Role of whole body FDG-PET imaging in predicting relapse of malignant lymphoma in patients with residual masses after treatment
- 31 August 1999
- journal article
- Published by Elsevier in Radiography
- Vol. 5 (3) , 155-163
- https://doi.org/10.1016/s1078-8174(99)90024-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Extranodal malignant lymphoma: detection with FDG PET versus CT.Radiology, 1998
- Regional Body FDG-PET in Postoperative Recurrent HyperparathyroidismJournal of Computer Assisted Tomography, 1997
- Evaluation of Pulmonary Lesions With FDG-PETChest, 1996
- Current role of gallium scanning in the management of lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- Gallium scanning in the management of mediastinal Hodgkin's diseaseEuropean Journal of Haematology, 1989
- Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.Radiology, 1987
- Residual fibrous masses in treated Hodgkin's diseaseCancer, 1987
- Radiation fibrosis: differentiation from recurrent tumor by MR imaging.Radiology, 1985
- Gallium-67 scanning: Limited usefulness in staging patients with non-Hodgkin's lymphomaThe American Journal of Medicine, 1980
- Benign Mass Lesions After Therapy for Hodgkin's DiseaseArchives of internal medicine (1960), 1979